06 September 2011 10:45 [Source: ICIS news]
LONDON (ICIS)--Evonik Industries is doubling its amino acid L-lysine capacity at its plant in ?xml:namespace>
The two-phase expansion is expected to be completed by August 2012, six months earlier than originally projected, Evonik added.
The company said it uses biotechnology to produce the amino acids L-lysine, L-threonine and L-tryptophan, which are used in animal nutrition.
“This investment further strengthens our significant market position in the feed additive business,” said Klaus Engel, CEO of Evonik Industries.
“We recently announced plans to construct a new plant [in Singapore] for expanding our [amino acid] DL-methionine capacity to 580,000 tonnes/year, and doubling our L-lysine capacities will now add further growth to our biotechnology-manufactured amino acid L-lysine as well,” he added.
“We’ve seen rising demand for our L-lysine in the
Evonik expects to bring the first additional quantities to the market in November 2011, when the first expansion phase is complete. The company added that it has already started the second expansion phase, for which all permits were granted in June 2011.
For more on Evonik visit ICIS company intelligence
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections